This facility derives partial funding from the FCCC Cancer Center Support Grant (CCSG) from the National Cancer Institute.
|Director||Erica A. Golemis, PhD|
|Manager||Margret Einarson, PhD
|W250 & 251
|Contact Margret Einarson for pricing and scheduling.|
The High Throughput Screening Facility provides screening platforms and specialized instrumentation for increased experimental throughput that enables investigators to perform hypothesis-generating discovery research in novel areas of translational research. We provide RNAi and compound libraries, along with the specialized instrumentation required for large scale screening. To maximize productivity, dedicated staff educate investigators in the best application of reagents to their research program. We also support investigators who are working to establish clinical correlates or novel technical capabilities, by performing assay development and executing projects requiring wet-bench capacity.